Peregrine Pharma (PPHM) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
LOSS FROM OPERATIONS: -11.08M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
LOSS FROM OPERATIONS: -11.08M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.16), versus ($0.40) reported last year. Revenue for the quarter came in at $17.9 million, versus $18.78 million reported last year.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
